Scisparc Ltd
NASDAQ:SPRC

Watchlist Manager
Scisparc Ltd Logo
Scisparc Ltd
NASDAQ:SPRC
Watchlist
Price: 1.4 USD 2.94% Market Closed
Market Cap: 4.6m USD

Scisparc Ltd
Investor Relations

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Oz Adler CPA
CEO & CFO
No Bio Available
Mr. Itschak Shrem
President & Director
No Bio Available
Dr. Adi Zuloff-Shani Ph.D.
Chief Technologies Officer
No Bio Available

Contacts

Address
TEL AVIV-YAFO
20 Raul Wallenberg Street, Tower A
Contacts
+97236103100
scisparc.com